The U.S. dairy alternatives market is forecasted to grow from $5.84 billion in 2022 to $14.28 billion by 2030, reflecting a significant consumer shift toward plant-based products VANCOUVER, BC, Jan.

Steak 'n Shake will cook its fries in 100% beef tallow by February 2025, replacing vegetable oils. The move follows growing criticism of seed oils, linked by some to health issues like obesity and ...

Bright-red Valentine’s Day candy hearts, strawberry-flavored ice pops and yogurt, some maraschino cherries, nutrition shakes, cough syrups and gummy vitamins — these are just some of the items that ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Steak n Shake announced that it is moving forward with the use of 100% all-natural beef tallow in all its restaurants. Steak n Shake has long been famous for its shoestring fries – and it will now fry ...

The popular fast-casual burger chain Shake Shack is offering a meal deal for New Yorkers dealing with congestion pricing woes. Act fast, as the restaurant’s Congestion Pricing Combo will be gone ...

You can mainly thank artificial intelligence and its most advanced chipsets for the company’s positive Q4. “Our business in the fourth quarter was supported by strong demand for our industry ...

A popular fast-food restaurant chain is expanding in the Cincinnati area, opening a second location this year.Shake Shack will open a second location in Clifton, inside the former Keystone Bar ...

The burger chain Shake Shack told investors on Monday that it plans to expand aggressively in the years ahead. Its goal is to eventually operate 1,500 stores. Currently, it has just over 300.

Mon, January 13, 2025 at 1:35 PM UTC ...

Meal replacement shakes are a convenient dietary supplement designed to help you meet your daily nutritional needs when a traditional meal isn't an option. Unlike standard protein shakes, they offer a ...

The FDA has granted fast track designation to emiltatug ledadotin for advanced or metastatic breast cancer treatment, as supported by new phase 1 data. The FDA granted fast track designation to ...